p53 is frequently mutated in Barrett's metaplasia of the intestinal type

被引:0
|
作者
Campomenosi, P
Conio, M
Bogliolo, M
Urbini, S
Assereto, P
Aprile, A
Monti, P
Aste, H
Lapertosa, G
Inga, A
Abbondandolo, A
Fronza, G
机构
[1] IST NAZL RIC CANC,CTR STUDY TUMORS,ENVIRONM ORIGINS MUTAGENESIS LAB,I-16132 GENOA,ITALY
[2] IST NAZL RIC CANC,GASTROENTEROL UNIT,I-16132 GENOA,ITALY
[3] UNIV GENOA,CHAIR ANAT PATHOL,GENOA,ITALY
[4] UNIV GENOA,CHAIR GENET,GENOA,ITALY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ms gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ms gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type (9 patients), combined I type (I + C +/- F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p53 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one I component. The association with the histotype was statistically significant (P < 0.03; pure I type versus non-I type; P < 0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I-type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 50 条
  • [21] Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer
    M-S Wu
    C-T Shun
    W-C Lee
    C-J Chen
    H-P Wang
    W-J Lee
    J-C Sheu
    J-T Lin
    British Journal of Cancer, 1998, 78 : 971 - 973
  • [22] Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer
    Wu, WS
    Shun, CT
    Lee, WC
    Chen, CJ
    Wang, HP
    Lee, WJ
    Sheu, JC
    Lin, JT
    BRITISH JOURNAL OF CANCER, 1998, 78 (07) : 971 - 973
  • [23] P53 Deficiency Accelerate Esophageal Epithelium Intestinal Metaplasia Malignancy
    Qiu, Quanpeng
    Guo, Gang
    Guo, Xiaolong
    Hu, Xiake
    Yu, Tianyu
    Liu, Gaixia
    Zhang, Haowei
    Chen, Yinnan
    She, Junjun
    BIOMEDICINES, 2023, 11 (03)
  • [24] p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach
    Kim, SS
    Bhang, CS
    Min, KO
    Chae, HS
    Choi, SW
    Lee, CD
    Lim, KW
    Chung, IS
    Park, DH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (04) : 490 - 496
  • [25] p53 and the malignant progression of Barrett's esophagus
    Merola, E
    Claudio, PP
    Giordano, A
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 206 (03) : 574 - 577
  • [26] A novel, highly effective, low cost method for identifying p53 mutations in Barrett's metaplasia.
    Yassin, R
    Korkko, J
    Prockop, D
    Reynolds, JC
    GASTROENTEROLOGY, 1999, 116 (04) : A363 - A363
  • [27] p53 and neoplastic progression in Barrett's esophagus
    Reid, BJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (05): : 1321 - 1323
  • [28] p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients
    Younes, Mamoun
    Brown, Keith
    Lauwers, Gregory Y.
    Ergun, Gulchin
    Meriano, Frank
    Schmulen, A. Carl
    Barroso, Alberto
    Ertan, Atilla
    HISTOPATHOLOGY, 2017, 71 (01) : 27 - 33
  • [29] Clinical use of p53 in Barrett's esophagus
    Keswani, Rajesh N.
    Noffsinger, Amy
    Waxman, Irving
    Bissonnette, Marc
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1243 - 1249
  • [30] Intestinal metaplasia in Barrett's esophagus (BE) is not related to intestinal metaplasia in the stomach.
    Gutierrez, O
    Cardona, H
    Ricaurte, O
    GASTROINTESTINAL ENDOSCOPY, 1996, 43 (04) : 183 - 183